No significant differences in sex, age, smoking history, KPS, tumor stage, histopathologic subtype, differentiated degree, or epidermal growth factor receptor (EGFR) mutation were found between the relatively-high-PD-L1-expression tumors and relatively-low-PD-L1-expression tumors. This evidence concerns the gene EGFR and neoplasm.